Stay updated on Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial
Sign up to get notified when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.

Latest updates to the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new page revision, v3.5.4, was added to the record history, replacing the previous v3.5.3 and signaling an update to the page's version metadata. This change reflects the latest build of the page rather than core content or functionality.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe update changes the displayed ClinicalTrials.gov page revision number from v3.5.2 to v3.5.3, reflecting a tooling/interface release rather than a modification to the trial record data.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision: v3.5.2 is now listed, replacing the previous Revision: v3.5.0.SummaryDifference0.1%

- Check52 days agoChange DetectedA new version entry was added to the Record History, reflecting updates to the study record such as status, design, eligibility, and contacts/locations.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision history shows the addition of v3.5.0 and the removal of v3.4.3.SummaryDifference0.1%

- Check81 days agoChange DetectedRecord History shows the addition of Revision: v3.4.3 and the deletion of Revision: v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.